• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Tedizolid

Eps15 homology domainCcontaining 2 (EHD2) is one of the EHD-containing protein

January 15, 2019 by Katherine Lewis Leave a Comment

Eps15 homology domainCcontaining 2 (EHD2) is one of the EHD-containing protein category of dynamin-related ATPases involved with membrane redesigning in the endosomal system. is necessary for caveolar localization. EHD2 had not been needed for the development or shaping of caveolae, but high degrees of EHD2 triggered distortion and lack of endogenous caveolae. Set up of … [Read more…]

Posted in: Blogging Tagged: Epha1, Tedizolid

We determined the possible function of large-conductance Ca2+-activated K+ (BK) stations

December 19, 2018 by Katherine Lewis Leave a Comment

We determined the possible function of large-conductance Ca2+-activated K+ (BK) stations in legislation of venous shade in little capacitance blood vessels and blood circulation pressure. properties in ion route control of venomotor shade, but also Tedizolid that BK stations are necessary for rhythmic oscillations in venous firmness. not only raises MAP, but also reduces venous … [Read more…]

Posted in: Blogging Tagged: Ctgf, Tedizolid

Background Cancerous inhibitor of PP2A (CIP2A) is usually a recently characterized

February 6, 2018 by Katherine Lewis Leave a Comment

Background Cancerous inhibitor of PP2A (CIP2A) is usually a recently characterized oncoprotein, which promotes cancer cell proliferation. also promotes lung malignancy cell expansion. By phospho-array, several kinase candidates were recognized, one of which is definitely c-Jun triggered kinases (JNK). The hit down of CIP2A decreased JNK phosphorylation, and the phosphorylation of downstream transcriptional factors, ATF2 … [Read more…]

Posted in: Blogging Tagged: Tedizolid

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by